Medical software Q-View™
analysisdata analysiscontrol

medical software
medical software
medical software
medical software
medical software
medical software
medical software
Add to favorites
Compare this product
 

Characteristics

Applications
medical
Function
analysis, data analysis, control, capture
Operating system
Windows

Description

w Software version 3.13 introduces new features to create a software environment compliant with 21 CFR Part 11. New features include: Electronic signatures. Audit trail to ensure data integrity. Customizable user roles allow administrators to control access to over 20 functions. Data Analysis Templates to further expedite the analysis process and increase compatibility with different LIS systems. These new features combined with existing LIS adaptability make the Q-View platform an excellent resource for your next multiplex ELISA-based project. Our Software Q-View Software is a tool for the quantitative analysis of multiplexed chemiluminescent planar-based arrays. Optimized for use with Q-Plex™ assays and run on the Q-View™ Imager LS, the software is also capable of analyzing images captured on a variety of other systems. Q-View Software helps users capture accurate, dependable data through: Unique product codes expedite workflow by filling spot location and standard curve information Automatically utilize the best regression model for each analyte by comparing the recovery of the calibrator 21 CFR Part 11 ready LIS adaptable Computer Specifications Run your Q-View Imager LS on most available lab computers* or purchase an optimized computer from Quansys. Recommended Computer Requirements - Minimum Computer Requirements Operating System: Windows 11, 10, 8, 7 (32 or 64-bit) - Operating System: Windows 11, 10, 8, 7 (32 or 64-bit) RAM: 4+ GB - RAM: 2 GB Processor: 2 or more processing cores
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.